Market Research

Dengue Vaccines Market – Current Impact to Make Big Changes | Sanofi Pasteur, Merck & Co, GlaxoSmithKline, Pfizer, Instituto Butantan

Jun 25, 2020 7:45 PM ET
iCrowd Newswire – Jun 25, 2020

Global Dengue Vaccines Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns& country along with competitive landscape, player’s market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions.

 Top players in Global Dengue Vaccines Market are:

Sanofi Pasteur Inc (France), Merck & Co Inc (United States), GlaxoSmithKline (United Kingdom ), Pfizer  (United States), Instituto Butantan (Brazil), Takeda Pharmaceutical Company Limited (Japan), Sun Pharmaceutical Industries Limited (India), GeneOne Life Science Inc  (South Korea), Medigen Vaccine Biologics Corporation (China), Merck Sharp & Dohme (United States)

Analyst at AMA have conducted special survey and have connected with opinion leaders and Industry experts from various region to minutely understand impact on growth as well as local reforms to fight the situation. A special chapter in the study presents Impact Analysis of COVID-19 on Global Dengue Vaccines Market along with tables and graphs related to various country and segments showcasing impact on growth trends.

 Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/769-global-dengue-vaccines-market

 Dengue is a viral disease transmitted by infected mosquitoes, particularly female mosquito of  Aedes aegypti responsible vector to transmit the virus that causes dengue. Dengue causes sudden fever and pain in the joints. While vaccines are preventive measures taken to cure any disease by facilitating immunity to develop protection from disease. It is a biological preparation that provides active acquired immunity, vaccines are consisting of substance-related to disease-causing microorganism and are sometimes made from weak or killed forms of the microbe, its toxins, or its proteins. Dengue vaccine is mainly CYD tetravalent dengue vaccine from Sanofi Pasteur (France)is leading for dengue vaccines. A live attenuated vaccine known as Dengvaxia, developed by Sanofi, launched and approved license in 2015. Dengvaxia is a mixture of four monovalent chimeric vaccine viruses, CYD-1, CYD-2, CYD-3, and CYD-4, produced using Vero cells. These four CYDs are based on the yellow fever virus (YFV) 17D vaccine vector backbone. First licenses approved in Mexico in 2015  for 9-45 individuals for 20 countries.

 Dengue Vaccines Market Segmentation:

by  Application (Prevention of dengue, Enhanced the immunity), End Users (Government organizations, Medical clinics, Non-profit Organization, Diagnostic centers), Vaccines (Live Attenuated Vaccines, Chimeric Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Nucleic Acid-Based Vaccines)

 Market Drivers

  • Growing Demand due to Rising in Infection Level

 Market Trend

  • Two New Live Attenuated Dengue Vaccines Are Currently In Phase Iii Efficacy Trials
  • Dsv4 Process Development And Scale-Up Work Are Currently In Progress

 Challenges

  • Dengue Vaccines Are Challenged By Critical Issues Like Lack Of Animal Models For The Disease And Absence Of Suitable Markers Of Protective Immunity
  • New Advances In Dengue Pathogenesis And Immune Response Will Shed Light On The Approach Needed To Make An Ideal Dengue Vaccine
  • Dengue Vaccines Banned In Philippines Due To Controversy

 Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

 Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/769-global-dengue-vaccines-market

 Strategic Points Covered in Table of Content of Global Dengue Vaccines Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Global Dengue Vaccines market

Chapter 2: Exclusive Summary – the basic information of the Global Dengue Vaccines Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Global Dengue Vaccines

Chapter 4: Presenting the Global Dengue Vaccines Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region 2013-2020

Chapter 6: Evaluating the leading manufacturers of the Global Dengue Vaccines market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Global Dengue Vaccines Market is a valuable source of guidance for individuals and companies.

 Data Sources & Methodology

The primary sources involve the industry experts from the Global Dengue Vaccines Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company’s Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weightage.

 Get More Information: https://www.advancemarketanalytics.com/reports/769-global-dengue-vaccines-market

 What benefits does AMA research studies provides?

  • Supporting company financial and cash flow planning
  • Open up New Markets
  • To Seize powerful market opportunities
  • Key decision in planning and to further expand market share
  • Identify Key Business Segments, Market proposition & Gap Analysis
  • Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies’ revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources; our analysts and consultants derive informative and usable data suited for our client’s business needs. The research study enables clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

Contact Information:

Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]

Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport


iCrowdNewswire

Keywords:    Dengue Vaccines Market Analysis, Dengue Vaccines Market Forecast, Dengue Vaccines Market Growth, Dengue Vaccines Market Opportunity, Dengue Vaccines Market Share, Dengue Vaccines Market Size, Dengue Vaccines Market Trends